Clinical Trials | December 13, 2023
Progenesis opens genetic laboratory in New Delhi and AI & Bioinformatics data centre in Chennai
Leading USA based genetic testing brand officially enters the Indian market
Leading USA based genetic testing brand officially enters the Indian market
New facility is part of Aptar Pharma’s global expansion program
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The product has been in-licensed from Strides and will be commercialized by Amneal
The company has received Form 483 with three observations
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated
